Skip to main content
Top
Published in: Journal of Neuro-Oncology 3/2013

01-05-2013 | Clinical Study

The influence of regional health system characteristics on the surgical management and receipt of post operative radiation therapy for glioblastoma multiforme

Authors: Sanjay Aneja, Dhruv Khullar, James B. Yu

Published in: Journal of Neuro-Oncology | Issue 3/2013

Login to get access

Abstract

Despite a known optimal treatment protocol for the management of glioblastoma multiforme (GBM), many patients fail to receive complete surgical resection or post-operative radiation therapy (PORT). The underlying reasons behind this disparity are unclear. Our study investigates the influence of regional health system resources on the surgical management and PORT receipt in patients with GBM. Surgical intervention, PORT receipt and patient data for patients diagnosed with GBM were obtained from the years 2004 to 2008 from the NCI Surveillance, Epidemiology, and End Results database and combined with the health system data from the Area Resource File. Four logistic models were constructed to test the effect of health system characteristics on surgical treatment choice and PORT receipt among health service areas (HSAs). We found that younger, married patients in HSAs with higher median incomes were significantly more likely to receive both gross total resection (p < 0.001, p < 0.001, p = 0.002) and PORT (p < 0.001, p < 0.001, p = 0.008). The density of radiation oncology equipped hospitals was also a significant predictor of PORT receipt (p = 0.002). Our findings suggest regional variations in of neuro-oncology services and income may have impact on GBM management. Policies aimed at narrowing disparities in treatment may need to focus on addressing regional variations in oncology resources.
Literature
1.
go back to reference Laws ER, Parney IF, Huang W, Anderson F, Morris AM, Asher A, Lillehei KO, Bernstein M, Brem H, Sloan A, Berger MS, Chang S (2003) Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg 99(3):467–473. doi:10.3171/jns.2003.99.3.0467 PubMedCrossRef Laws ER, Parney IF, Huang W, Anderson F, Morris AM, Asher A, Lillehei KO, Bernstein M, Brem H, Sloan A, Berger MS, Chang S (2003) Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg 99(3):467–473. doi:10.​3171/​jns.​2003.​99.​3.​0467 PubMedCrossRef
4.
go back to reference Ricketts TCHG (2007) Mortality and physician supply: does region hold the key to the paradox? Health Serv Res 42(6):2233–2251PubMedCrossRef Ricketts TCHG (2007) Mortality and physician supply: does region hold the key to the paradox? Health Serv Res 42(6):2233–2251PubMedCrossRef
6.
go back to reference Kociol RD, Greiner MA, Fonarow GC, Hammill BG, Heidenreich PA, Yancy CW, Peterson ED, Curtis LH, Hernandez AF (2011) Associations of patient demographic characteristics and regional physician density with early physician follow-up among medicare beneficiaries hospitalized with heart failure. Am J Cardiol 108(7):985–991. doi:10.1016/j.amjcard.2011.05.032 PubMedCrossRef Kociol RD, Greiner MA, Fonarow GC, Hammill BG, Heidenreich PA, Yancy CW, Peterson ED, Curtis LH, Hernandez AF (2011) Associations of patient demographic characteristics and regional physician density with early physician follow-up among medicare beneficiaries hospitalized with heart failure. Am J Cardiol 108(7):985–991. doi:10.​1016/​j.​amjcard.​2011.​05.​032 PubMedCrossRef
7.
go back to reference Starfield B, Shi L, Grover A, Macinko J (2005) The effects of specialist supply on populations’ health: assessing the evidence. Health Aff (Millwood) Suppl Web Exclusives:W5-97–W5-107. doi:10.1377/hlthaff.w5.97 Starfield B, Shi L, Grover A, Macinko J (2005) The effects of specialist supply on populations’ health: assessing the evidence. Health Aff (Millwood) Suppl Web Exclusives:W5-97–W5-107. doi:10.​1377/​hlthaff.​w5.​97
12.
go back to reference US Department of Health and Human Services HRaSA Area Resource File (ARF): National county-level health resource information database. http://www.arfsys.com. Accessed 18 March 2012 US Department of Health and Human Services HRaSA Area Resource File (ARF): National county-level health resource information database. http://​www.​arfsys.​com. Accessed 18 March 2012
13.
go back to reference Park HS, Gross CP, Makarov DV, Yu JB (2012) Immortal time bias: a frequently unrecognized threat to validity in the evaluation of postoperative radiotherapy. Int J Radiat Oncol Biol Phys. doi:10.1016/j.ijrobp.2011.10.025 Park HS, Gross CP, Makarov DV, Yu JB (2012) Immortal time bias: a frequently unrecognized threat to validity in the evaluation of postoperative radiotherapy. Int J Radiat Oncol Biol Phys. doi:10.​1016/​j.​ijrobp.​2011.​10.​025
14.
go back to reference Koshy MVJ, Dolecek TA, Howard A, Mahmood U, Chmura SJ, Weichselbaum RR, McCarthy BJ (2012) Improved survival time trends for glioblastoma using the SEER 17 population-based registries. J Neurooncol 107(1):207–212PubMedCrossRef Koshy MVJ, Dolecek TA, Howard A, Mahmood U, Chmura SJ, Weichselbaum RR, McCarthy BJ (2012) Improved survival time trends for glioblastoma using the SEER 17 population-based registries. J Neurooncol 107(1):207–212PubMedCrossRef
15.
go back to reference Kramm CM, Wagner S, Van Gool S, Schmid H, Strater R, Gnekow A, Rutkowski S, Wolff JE (2006) Improved survival after gross total resection of malignant gliomas in pediatric patients from the HIT-GBM studies. Anticancer Res 26(5B):3773–3779PubMed Kramm CM, Wagner S, Van Gool S, Schmid H, Strater R, Gnekow A, Rutkowski S, Wolff JE (2006) Improved survival after gross total resection of malignant gliomas in pediatric patients from the HIT-GBM studies. Anticancer Res 26(5B):3773–3779PubMed
16.
go back to reference Aghi M BF, Curry WT, Carter BS (2004) Survival after biopsy or resection of supratentorial lobar glioblastoma multiforme: a population-based study, In: Invited talk, congress of neurological surgeons annual meeting Aghi M BF, Curry WT, Carter BS (2004) Survival after biopsy or resection of supratentorial lobar glioblastoma multiforme: a population-based study, In: Invited talk, congress of neurological surgeons annual meeting
17.
go back to reference Shinoda J, Sakai N, Murase S, Yano H, Matsuhisa T, Funakoshi T (2001) Selection of eligible patients with supratentorial glioblastoma multiforme for gross total resection. J Neurooncol 52(2):161–171PubMedCrossRef Shinoda J, Sakai N, Murase S, Yano H, Matsuhisa T, Funakoshi T (2001) Selection of eligible patients with supratentorial glioblastoma multiforme for gross total resection. J Neurooncol 52(2):161–171PubMedCrossRef
20.
go back to reference Keime-Guibert F, Chinot O, Taillandier L, Cartalat-Carel S, Frenay M, Kantor G, Guillamo JS, Jadaud E, Colin P, Bondiau PY, Menei P, Loiseau H, Bernier V, Honnorat J, Barrie M, Mokhtari K, Mazeron JJ, Bissery A, Delattre JY (2007) Radiotherapy for glioblastoma in the elderly. N Engl J Med 356(15):1527–1535. doi:10.1056/NEJMoa065901 PubMedCrossRef Keime-Guibert F, Chinot O, Taillandier L, Cartalat-Carel S, Frenay M, Kantor G, Guillamo JS, Jadaud E, Colin P, Bondiau PY, Menei P, Loiseau H, Bernier V, Honnorat J, Barrie M, Mokhtari K, Mazeron JJ, Bissery A, Delattre JY (2007) Radiotherapy for glioblastoma in the elderly. N Engl J Med 356(15):1527–1535. doi:10.​1056/​NEJMoa065901 PubMedCrossRef
21.
go back to reference Kristiansen K, Hagen S, Kollevold T, Torvik A, Holme I, Nesbakken R, Hatlevoll R, Lindgren M, Brun A, Lindgren S, Notter G, Andersen AP, Elgen K (1981) Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Study Group. Cancer 47(4):649–652PubMedCrossRef Kristiansen K, Hagen S, Kollevold T, Torvik A, Holme I, Nesbakken R, Hatlevoll R, Lindgren M, Brun A, Lindgren S, Notter G, Andersen AP, Elgen K (1981) Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Study Group. Cancer 47(4):649–652PubMedCrossRef
22.
go back to reference Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–996. doi:10.1056/NEJMoa043330 PubMedCrossRef Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352(10):987–996. doi:10.​1056/​NEJMoa043330 PubMedCrossRef
24.
go back to reference Lawrence YR, Mishra MV, Werner-Wasik M, Andrews DW, Showalter TN, Glass J, Shen X, Symon Z, Dicker AP (2011) Improving prognosis of glioblastoma in the 21st century: who has benefited most? Cancer 118(17):4228–4234PubMedCrossRef Lawrence YR, Mishra MV, Werner-Wasik M, Andrews DW, Showalter TN, Glass J, Shen X, Symon Z, Dicker AP (2011) Improving prognosis of glioblastoma in the 21st century: who has benefited most? Cancer 118(17):4228–4234PubMedCrossRef
25.
go back to reference Sun M, Abdollah F, Liberman D, Abdo A, Thuret R, Tian Z, Shariat SF, Montorsi F, Perrotte P, Karakiewicz PI (2011) Racial disparities and socioeconomic status in men diagnosed with testicular germ cell tumors: a survival analysis. Cancer 117(18):4277–4285. doi:10.1002/cncr.25969 PubMedCrossRef Sun M, Abdollah F, Liberman D, Abdo A, Thuret R, Tian Z, Shariat SF, Montorsi F, Perrotte P, Karakiewicz PI (2011) Racial disparities and socioeconomic status in men diagnosed with testicular germ cell tumors: a survival analysis. Cancer 117(18):4277–4285. doi:10.​1002/​cncr.​25969 PubMedCrossRef
26.
go back to reference Reyes-Ortiz CAGJ, Zhang DD, Freeman JL (2011) Socioeconomic status and chemotherapy use for melanoma in older people. Can J Aging 1:1–11 Reyes-Ortiz CAGJ, Zhang DD, Freeman JL (2011) Socioeconomic status and chemotherapy use for melanoma in older people. Can J Aging 1:1–11
31.
go back to reference Evens AM, Antillon M, Aschebrook-Kilfoy B, Chiu BC (2012) Racial disparities in Hodgkin’s lymphoma: a comprehensive population-based analysis. Ann Oncol. doi:10.1093/annonc/mdr578 Evens AM, Antillon M, Aschebrook-Kilfoy B, Chiu BC (2012) Racial disparities in Hodgkin’s lymphoma: a comprehensive population-based analysis. Ann Oncol. doi:10.​1093/​annonc/​mdr578
33.
go back to reference Terplan MSN, McNamara EJ, Tracy JK, Temkin SM (2012) Have racial disparities in ovarian cancer increased over time? An analysis of SEER data. Gynecol Oncol 125(1):19–24PubMedCrossRef Terplan MSN, McNamara EJ, Tracy JK, Temkin SM (2012) Have racial disparities in ovarian cancer increased over time? An analysis of SEER data. Gynecol Oncol 125(1):19–24PubMedCrossRef
34.
go back to reference Wick W, Platten M, Meisner C, Felsberg J, Tabatabai G, Simon M, Nikkhah G, Papsdorf K, Steinbach JP, Sabel M, Combs SE, Vesper J, Braun C, Meixensberger J, Ketter R, Mayer-Steinacker R, Reifenberger G, Weller M (2012) Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial. Lancet Oncol 13(7):707–715. doi:10.1016/S1470-2045(12)70164-X PubMedCrossRef Wick W, Platten M, Meisner C, Felsberg J, Tabatabai G, Simon M, Nikkhah G, Papsdorf K, Steinbach JP, Sabel M, Combs SE, Vesper J, Braun C, Meixensberger J, Ketter R, Mayer-Steinacker R, Reifenberger G, Weller M (2012) Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial. Lancet Oncol 13(7):707–715. doi:10.​1016/​S1470-2045(12)70164-X PubMedCrossRef
35.
go back to reference Jagsi R, Abrahamse P, Hawley ST, Graff JJ, Hamilton AS, Katz SJ (2012) Underascertainment of radiotherapy receipt in surveillance, Epidemiology, and End Results registry data. Cancer 118(2):333–341. doi:10.1002/cncr.26295 PubMedCrossRef Jagsi R, Abrahamse P, Hawley ST, Graff JJ, Hamilton AS, Katz SJ (2012) Underascertainment of radiotherapy receipt in surveillance, Epidemiology, and End Results registry data. Cancer 118(2):333–341. doi:10.​1002/​cncr.​26295 PubMedCrossRef
Metadata
Title
The influence of regional health system characteristics on the surgical management and receipt of post operative radiation therapy for glioblastoma multiforme
Authors
Sanjay Aneja
Dhruv Khullar
James B. Yu
Publication date
01-05-2013
Publisher
Springer US
Published in
Journal of Neuro-Oncology / Issue 3/2013
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-013-1068-8

Other articles of this Issue 3/2013

Journal of Neuro-Oncology 3/2013 Go to the issue